Arena Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.12.21	US-Pharmariese Pfizer will Arena Pharmaceuticals schlucken (AWP)
12.04.18	New Private Equity Firm Established in Carlsbad (PR Newswire)
11.04.18	LIONSGATE ANNOUNCES WORLD PREMIERE OF THE HUNGER GAMES IN CONCERT GLOBAL TOUR (PR Newswire)
05.01.18	NMI® at 55.9%; December Non-Manufacturing ISM® Report On Business® (PR Newswire)
20.09.17	Aytu BioScience to Present at 2017 BioPharm America Conference (PR Newswire)
31.07.17	Mercury General Corporation Announces Second Quarter Results and Declares Quarterly Dividend (PR Newswire)
17.07.17	Shopkins by Moose Toys And Coolhaus Partner to Release Exclusive Ice Cream Flavor Celebrating Limited Edition Shoppie Doll (PR Newswire)
29.06.17	Arena Pharmaceuticals Completes Trial Comparing Once-Daily, Extended Release Formulation of Ralinepag with Twice-Daily, Immediate Release Formulation in Normal Healthy Volunteers (PR Newswire)
20.06.17	Gainers & Losers Of June 19: ARNA, NVDQ, CLVS, RWLK, CLSN... (RTTNews)
15.06.17	Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference (PR Newswire)
14.06.17	Arena Pharmaceuticals Announces Shareholders and Board of Directors Approve Reverse Stock Split (PR Newswire)
14.06.17	Arena Pharmaceuticals Appoints Jennifer Jarrett to Board of Directors (PR Newswire)
01.06.17	Arena Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference June 9th (PR Newswire)
16.05.17	Arena Pharmaceuticals to Present Phase 1 Data on Ralinepag for Treatment of Pulmonary Arterial Hypertension at the American Thoracic Society 2017 International Conference (PR Newswire)
10.05.17	EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q1 Earnings Report (RTTNews)
09.05.17	Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2017 Financial Results (PR Newswire)
02.05.17	Arena Pharmaceuticals to Release First Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, May 9, 2017 (PR Newswire)
21.04.17	Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares (PR Newswire)
18.04.17	Arena Pharmaceuticals Falls Sharply After Pricing Offering (RTTNews)
18.04.17	Arena Pharma Prices Offering Of 60 Mln Shares At $1.15/shr (RTTNews)
18.04.17	Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock (PR Newswire)
17.04.17	Arena Pharmaceuticals Announces Multiple Presentations at ASPET 2017 at Experimental Biology (PR Newswire)
13.04.17	Biotech Stocks on Investors' Radar -- Halozyme Therapeutics, Cara Therapeutics, PDL BioPharma, and Arena Pharma (PR Newswire)
20.03.17	Arena Pharmaceuticals Appoints Dr. Preston Klassen, M.D., M.H.S. as Executive Vice President, Research and Development and Chief Medical Officer (PR Newswire)
16.03.17	Gainers & Losers Of Mar.15: CERU, CPRX, ARNA, AKAO, GNCA... (RTTNews)
14.03.17	EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q4 Earnings Report (RTTNews)
14.03.17	Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results (PR Newswire)
08.03.17	Arena Pharmaceuticals to Present at the 27th Annual Oppenheimer Healthcare Conference (PR Newswire)
28.02.17	Technical Reports on Biotech Stocks -- ZIOPHARM Oncology, Aurinia Pharma, Arena Pharma, and Marinus Pharma (PR Newswire)
14.02.17	Arena Pharmaceuticals Appoints Three New Members to Board of Directors (PR Newswire)
09.02.17	Arena Pharmaceuticals Announces Three Upcoming Presentations at the 12th Congress of European Crohn's and Colitis Organisation - Inflammatory Bowel Diseases 2017 (PR Newswire)
17.01.17	Technical Reports on Biotech Stocks -- ContraVir Pharma, Arena Pharma, Neuralstem, and CTI BioPharma (PR Newswire)
04.01.17	Arena Pharmaceuticals and Eisai Amend Marketing and Supply Agreement for BELVIQ Globally (PR Newswire)
19.12.16	Eisai and Arena Pharmaceuticals Announce Regulatory Approval of BELVIQ® (lorcaserin HCl) in Brazil (PR Newswire)
08.12.16	NWBO To Leave Nasdaq, Voyager Cruises Ahead, Watch Out For REGN (RTTNews)
30.11.16	Arena Pharmaceuticals Announces Four Upcoming Presentations at the 2016 Advances in Inflammatory Bowel Diseases: Crohn's & Colitis Foundation's Clinical and Research Conference (PR Newswire)
23.11.16	Biotech Stocks Under Scanner -- PTC Therapeutics, Arena Pharma, BioDelivery Sciences, and Seres Therapeutics (PR Newswire)
07.11.16	EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q3 Earnings Report (RTTNews)
03.10.16	Eisai, Arena Pharma Announce Availability Of Belviq XR Tablets - Quick Facts (RTTNews)
08.08.16	EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q2 Earnings Report (RTTNews)
20.07.16	SCLN Withdraws From Auction Block, ZFGN Tumbles, Double Blessing For VRX (RTTNews)
15.07.16	Watch Out For BCLI, RARE's Phase 3 Trial Hits Goal, JUNO Opens Wallet (RTTNews)
14.07.16	Eisai And Arena Pharma Announce Regulatory Approval Of VENESPRI In Mexico (RTTNews)
15.06.16	Arena Pharma Names Kevin Lind EVP & CFO - Quick Facts (RTTNews)
09.05.16	EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q1 Earnings Report (RTTNews)
29.02.16	EARNINGS SUMMARY: Details of Arena Pharmaceutical Inc. Q4 Earnings Report (RTTNews)
13.01.16	ABBV All Set, PSTI Moving Ahead, Watch Out For ADMS (RTTNews)
30.11.15	Arena, Eisai Says FDA Accepts NDA For Lorcaserin Extended Release Formulation (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
22.11.24		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester
21.11.24		Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone
20.11.24		Dow Jones aktuell: Dow Jones liegt zum Handelsende im Plus
20.11.24		Anleger in New York halten sich zurück: Dow Jones leichter

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

22.11.24

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

22.11.24

Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester

21.11.24

Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone

20.11.24

Dow Jones aktuell: Dow Jones liegt zum Handelsende im Plus